An Update on Further Progression of NAFLD, NASH with Prospective Therapies Like L-Carnitine (LC), Nicotinamide Ribose (NR) Combination, as well as Apical Sodium Dependent Bile Acids Transporter (ASBT) or Volixibat and Silybin as Alternatives. Issue 3 (2020)

Record Type:: Journal Article
Title:: An Update on Further Progression of NAFLD, NASH with Prospective Therapies Like L-Carnitine (LC), Nicotinamide Ribose (NR) Combination, as well as Apical Sodium Dependent Bile Acids Transporter (ASBT) or Volixibat and Silybin as Alternatives. Issue 3 (2020)
Main Title:: An Update on Further Progression of NAFLD, NASH with Prospective Therapies Like L-Carnitine (LC), Nicotinamide Ribose (NR) Combination, as well as Apical Sodium Dependent Bile Acids Transporter (ASBT) or Volixibat and Silybin as Alternatives
Authors:: Kaur, Kulvinder Kochar
Allahbadia, Gautam
Singh, Mandeep
Is Part Of:: International journal of clinical and medical cases. Volume 3:Issue 3(2020:Mar.)
Journal:: International journal of clinical and medical cases
Issue:: Volume 3:Issue 3(2020:Mar.)
Issue Display:: Volume 3, Issue 3 (2020)
Year:: 2020
Volume:: 3
Issue:: 3
Issue Sort Value:: 2020-0003-0003-0000
Page Start:
Page End:
Publication Date:: 2020
Subjects:: Clinical medicine -- Case studies
Internal medicine -- Case studies
616.09
Journal URLs:: https://www.boffinaccess.com/journals/clinical-and-medical-cases/current-issue.php ↗
DOI:: 10.31021/ijcmc.20203138 ↗
Languages:: English
ISSNs:: 2517-7346
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library HMNTS - ELD Digital store
Ingest File:: 13191.xml